Incidence of high-risk acute coronary syndromes and eligibility for glycoprotein IIb/IIIa inhibitors among patients admitted for possible myocardial ischemia.

Abstract

OBJECTIVE Recent studies have demonstrated that glycoprotein (GP) IIb/IIIa inhibitors can reduce cardiac events in patients with acute coronary syndromes (ACS). However, little is known about how many patients are actually eligible for treatment. Our purpose was to determine how many patients admitted for possible myocardial infarction (MI) meet GP IIb/IIIa… (More)

Topics

Cite this paper

@article{Kontos2002IncidenceOH, title={Incidence of high-risk acute coronary syndromes and eligibility for glycoprotein IIb/IIIa inhibitors among patients admitted for possible myocardial ischemia.}, author={Michael Christopher Kontos and Joseph P. Ornato and Kristin L Schmidt and James L. Tatum and Robert L. Jesse}, journal={American heart journal}, year={2002}, volume={143 1}, pages={70-5} }